Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Vera Golder's publication output changed over time?
ScholarIQpublication output · 2013–2026
Output declined50% over the shown period — from 2 works in 2013 to 1 in 2026.
2
2
3
1
1
1
1
2013201720192020202220232026
What are the most-cited papers on Vera Golder?
ScholarIQmost cited works
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study
Vera Golder, Rangi Kandane‐Rathnayake, Molla Huq, Hieu T. Nim, Worawit Louthrenoo, Shue Fen Luo, Yeong‐Jian Jan Wu, Aisha Lateef, Sargunan Sockalingam, Sandra Navarra, Leonid Zamora, Laniyati Hamijoyo, Yasuhiro Katsumata, Masayoshi Harigai, Madelynn Chan, Sean O’Neill, Fiona Goldblatt, Chak Sing Lau, Zhan Guo Li, Alberta Hoi, Mandana Nikpour, Eric F. Morand
S4210233594. 2019170 Citations
Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study
Vera Golder, Rangi Kandane‐Rathnayake, Alberta Hoi, Molla Huq, Worawit Louthrenoo, Yuan An, Zhan Guo Li, Shue Fen Luo, Sargunan Sockalingam, Chak Sing Lau, Mo Yin Mok, Aisha Lateef, Kate Franklyn, Susan Morton, Sandra Navarra, Leonid Zamora, Yeong-Jian Jan Wu, Laniyati Hamijoyo, Madelynn Chan, Sean O’Neill, Fiona Goldblatt, Mandana Nikpour, Eric F. Morand
Arthritis Research & Therapy. 2017142 CitationsOPEN ACCESS
Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus
Shereen Oon, Molla Huq, Vera Golder, Pei Xuan Ong, Eric F. Morand, Mandana Nikpour
Annals of the Rheumatic Diseases. 201991 Citations
Discordance of patient and physician health status concerns in systemic lupus erythematosus
Vera Golder, James Jian Yun Ooi, A S Antony, Tina Ko, Susan Morton, Rangi Kandane‐Rathnayake, Eric F. Morand, Alberta Hoi
Lupus. 201789 Citations
Related on ScholarIQ
Novartis (Switzerland)
Institution
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study
Paper
Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study
Paper
Ankylosing spondylitis: an update.
Paper
Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus
Paper
Discordance of patient and physician health status concerns in systemic lupus erythematosus
Paper